FR3080621B1 - Nouvelle classe d'immunoglobuline recombinante de type g : igg5, codee par le pseudo-gene gamma humain de chaine lourde - Google Patents

Nouvelle classe d'immunoglobuline recombinante de type g : igg5, codee par le pseudo-gene gamma humain de chaine lourde Download PDF

Info

Publication number
FR3080621B1
FR3080621B1 FR1853681A FR1853681A FR3080621B1 FR 3080621 B1 FR3080621 B1 FR 3080621B1 FR 1853681 A FR1853681 A FR 1853681A FR 1853681 A FR1853681 A FR 1853681A FR 3080621 B1 FR3080621 B1 FR 3080621B1
Authority
FR
France
Prior art keywords
igg5
recombinant
gene
encoded
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1853681A
Other languages
English (en)
Other versions
FR3080621A1 (fr
Inventor
Michel Cogne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre Hospitalier Univ De Limoges
Centre National de la Recherche Scientifique CNRS
Francais du Sang Ets
Universite de Limoges
Original Assignee
Centre Hospitalier Univ De Limoges
Centre National de la Recherche Scientifique CNRS
Francais du Sang Ets
Universite de Limoges
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Hospitalier Univ De Limoges, Centre National de la Recherche Scientifique CNRS, Francais du Sang Ets, Universite de Limoges filed Critical Centre Hospitalier Univ De Limoges
Priority to FR1853681A priority Critical patent/FR3080621B1/fr
Priority to EP19725033.5A priority patent/EP3784698A1/fr
Priority to PCT/EP2019/060764 priority patent/WO2019207120A1/fr
Priority to US17/050,403 priority patent/US20210139599A1/en
Priority to CN201980028507.9A priority patent/CN112262154A/zh
Publication of FR3080621A1 publication Critical patent/FR3080621A1/fr
Application granted granted Critical
Publication of FR3080621B1 publication Critical patent/FR3080621B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
FR1853681A 2018-04-26 2018-04-26 Nouvelle classe d'immunoglobuline recombinante de type g : igg5, codee par le pseudo-gene gamma humain de chaine lourde Expired - Fee Related FR3080621B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR1853681A FR3080621B1 (fr) 2018-04-26 2018-04-26 Nouvelle classe d'immunoglobuline recombinante de type g : igg5, codee par le pseudo-gene gamma humain de chaine lourde
EP19725033.5A EP3784698A1 (fr) 2018-04-26 2019-04-26 Immunoglobulines recombinées d'une nouvelle classe d'igg5, codées par le gène pseudo-gamma de chaîne lourde humaine
PCT/EP2019/060764 WO2019207120A1 (fr) 2018-04-26 2019-04-26 Immunoglobulines recombinées d'une nouvelle classe d'igg5, codées par le gène pseudo-gamma de chaîne lourde humaine
US17/050,403 US20210139599A1 (en) 2018-04-26 2019-04-26 Recombinant immunoglobulins of a new igg5 class, encoded by the human heavy chain pseudo-gamma gene
CN201980028507.9A CN112262154A (zh) 2018-04-26 2019-04-26 人类重链伪γ基因编码的新型IGG5类重组免疫球蛋白

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1853681A FR3080621B1 (fr) 2018-04-26 2018-04-26 Nouvelle classe d'immunoglobuline recombinante de type g : igg5, codee par le pseudo-gene gamma humain de chaine lourde
FR1853681 2018-04-26

Publications (2)

Publication Number Publication Date
FR3080621A1 FR3080621A1 (fr) 2019-11-01
FR3080621B1 true FR3080621B1 (fr) 2022-12-09

Family

ID=65031194

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1853681A Expired - Fee Related FR3080621B1 (fr) 2018-04-26 2018-04-26 Nouvelle classe d'immunoglobuline recombinante de type g : igg5, codee par le pseudo-gene gamma humain de chaine lourde

Country Status (5)

Country Link
US (1) US20210139599A1 (fr)
EP (1) EP3784698A1 (fr)
CN (1) CN112262154A (fr)
FR (1) FR3080621B1 (fr)
WO (1) WO2019207120A1 (fr)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5959177A (en) 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
EP0604580A1 (fr) 1991-09-19 1994-07-06 Genentech, Inc. EXPRESSION DANS L'E. COLI DE FRAGMENTS D'ANTICORPS POSSEDANT AU MOINS UNE CYSTEINE PRESENTE SOUS FORME D'UN THIOL LIBRE, ET LEUR UTILISATION DANS LA PRODUCTION D'ANTICORPS BIFONCTIONNELS F(ab') 2?
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
US6040498A (en) 1998-08-11 2000-03-21 North Caroline State University Genetically engineered duckweed
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
KR100797667B1 (ko) 1999-10-04 2008-01-23 메디카고 인코포레이티드 외래 유전자의 전사를 조절하는 방법
EP2278020A3 (fr) * 2002-04-09 2011-05-11 Nationwide Children's Hospital, Inc. Transfert de gène d'anticorps et virus recombinants adeno-associés utilisés à cet effet
JPWO2008062904A1 (ja) * 2006-11-21 2010-03-04 独立行政法人理化学研究所 トランスジーンの安定的発現を可能にする方法
ES2828627T3 (es) * 2008-04-25 2021-05-27 Kyowa Kirin Co Ltd Anticuerpo multivalente estable
GB201107170D0 (en) * 2011-04-28 2011-06-15 Clark Michael Binding molecules with biased recognition
IN2015MN00139A (fr) * 2012-09-25 2015-10-16 Glenmark Pharmaceuticals Sa

Also Published As

Publication number Publication date
EP3784698A1 (fr) 2021-03-03
FR3080621A1 (fr) 2019-11-01
CN112262154A (zh) 2021-01-22
WO2019207120A1 (fr) 2019-10-31
US20210139599A1 (en) 2021-05-13

Similar Documents

Publication Publication Date Title
IL285782A (en) Compounds, compositions, and methods for treating disease
IL279144A (en) Tetrahydro-1H-pyrazino[2,1-azisoindolylquinoline compounds for the treatment of immune system disease
MA54521A (fr) Dérivés d'oxopyridine substitués
ZA202007649B (en) Virus and antigen purification and conjugation
MA52897A (fr) Diminution de l'activité immunitaire par modulation de facteurs de signalisation post-cellulaire
DK3720433T3 (da) Bis-cholin-tetrathiomolybdat til behandling af wilsons sygdom
SG11202008032YA (en) Novel calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferatory agents
SG11202101807SA (en) Improved synthesis of 1,4-diazaspiro[5.5]undecan-3-one
MA53875A (fr) Traitement avec des compositions d'igg hautement sialylées
FR3080621B1 (fr) Nouvelle classe d'immunoglobuline recombinante de type g : igg5, codee par le pseudo-gene gamma humain de chaine lourde
CL2020000187S1 (es) Cepillo dental.
DK3886858T3 (da) Forbindelser til behandling af øjensygdomme forbundet med for megen vaskularisering
UA39755S (uk) Каблучка «ланцюг»
UA39060S (uk) Ліжко-трансформер дитяче багатофункціональне
UA39477S (uk) Дитяча гірка для катання
UA39478S (uk) Дитяча гірка для катання
UA41439S (uk) М'ясорубка
SG11202101660PA (en) Composition for preventing infection with human immunodeficiency virus
UA40496S (uk) М'ясорубка
UA40402S (uk) М'ясорубка
GB201908319D0 (en) Pionka's truffin
UA40974S (uk) Торт «херсон»
GB201911707D0 (en) The "Pushy"
Pratiwi PENGEMBANGAN SUMBER DAYA MENUJU MASYARAKAT MADANI BERKEARIFAN LOKAL KABUPATEN PURBALINGGA
IT201900021909A1 (it) Stampella ortopedica elettromeccanica "pinfarina"

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20191101

PLFP Fee payment

Year of fee payment: 3

ST Notification of lapse

Effective date: 20201209

RN Application for restoration

Effective date: 20210127

FC Decision of inpi director general to approve request for restoration

Effective date: 20210205

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7